Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Synthetic cannabinoids.

Antoniou T, Juurlink DN.

CMAJ. 2014 Feb 18;186(3):210. doi: 10.1503/cmaj.130510. Epub 2013 Oct 7. No abstract available.

2.

Notes from the field: Severe illness associated with synthetic cannabinoid use - Brunswick, Georgia, 2013.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Nov 22;62(46):939.

3.

Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon.

Jerry J, Collins G, Streem D.

Cleve Clin J Med. 2012 Apr;79(4):258-64. doi: 10.3949/ccjm.79a.11147. Review.

4.

Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.

Kasper AM, Ridpath AD, Arnold JK, Chatham-Stephens K, Morrison M, Olayinka O, Parker C, Galli R, Cox R, Preacely N, Anderson J, Kyle PB, Gerona R, Martin C, Schier J, Wolkin A, Dobbs T.

MMWR Morb Mortal Wkly Rep. 2015 Oct 9;64(39):1121-2. doi: 10.15585/mmwr.mm6439a7.

5.

Notes from the field: severe illness associated with reported use of synthetic marijuana - Colorado, August-September 2013.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Dec 13;62(49):1016-7.

6.
7.

Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.

Seely KA, Patton AL, Moran CL, Womack ML, Prather PL, Fantegrossi WE, Radominska-Pandya A, Endres GW, Channell KB, Smith NH, McCain KR, James LP, Moran JH.

Forensic Sci Int. 2013 Dec 10;233(1-3):416-22. doi: 10.1016/j.forsciint.2013.10.002. Epub 2013 Oct 14.

PMID:
24314548
8.

Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.

Thornton SL, Lo J, Clark RF, Wu AH, Gerona RR.

Clin Toxicol (Phila). 2012 Dec;50(10):1165-8. doi: 10.3109/15563650.2012.744996. Epub 2012 Nov 20.

PMID:
23163617
9.

Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.

Gurdal F, Asirdizer M, Aker RG, Korkut S, Gocer Y, Kucukibrahimoglu EE, Ince CH.

J Forensic Leg Med. 2013 Aug;20(6):667-72. doi: 10.1016/j.jflm.2013.03.041. Epub 2013 Apr 28.

PMID:
23910858
10.

Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.

Shanks KG, Dahn T, Behonick G, Terrell A.

J Anal Toxicol. 2012 Jul;36(6):360-71. doi: 10.1093/jat/bks047. Epub 2012 May 14.

PMID:
22586208
11.

Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.

Ammann J, McLaren JM, Gerostamoulos D, Beyer J.

J Anal Toxicol. 2012 Jul;36(6):372-80. doi: 10.1093/jat/bks048. Epub 2012 May 16.

PMID:
22593567
12.

Nephrotoxic effects of designer drugs: synthetic is not better!

Luciano RL, Perazella MA.

Nat Rev Nephrol. 2014 Jun;10(6):314-24. doi: 10.1038/nrneph.2014.44. Epub 2014 Mar 25. Review.

PMID:
24662435
13.
14.

Synthetic cannabinoids: a new frontier of designer drugs.

Gunderson EW.

Ann Intern Med. 2013 Oct 15;159(8):563-4. No abstract available.

PMID:
24018791
15.

Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.

Musah RA, Domin MA, Walling MA, Shepard JR.

Rapid Commun Mass Spectrom. 2012 May 15;26(9):1109-14. doi: 10.1002/rcm.6205.

PMID:
22467461
16.

[Synthetic cannabinoids--the new "legal high" drugs].

Berkovitz R, Arieli M, Marom E.

Harefuah. 2011 Dec;150(12):884-7, 937. Hebrew.

PMID:
22352277
17.

Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs.

Grabenauer M, Krol WL, Wiley JL, Thomas BF.

Anal Chem. 2012 Jul 3;84(13):5574-81. doi: 10.1021/ac300509h. Epub 2012 Jun 20.

18.

Synthetic legal intoxicating drugs (April 2012).

Chandiramani RN.

Cleve Clin J Med. 2012 Aug;79(8):534; author reply 534-5. doi: 10.3949/ccjm.79c.08001. No abstract available.

19.

[Effect and occurrence of synthetic cannabinoids].

Tuv SS, Strand MC, Karinen R, Øiestad EL, Christophersen AS, Vindenes V.

Tidsskr Nor Laegeforen. 2012 Oct 30;132(20):2285-8. doi: 10.4045/tidsskr.12.0471. Review. Norwegian.

20.

"Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.

Järbe TU, Gifford RS.

Life Sci. 2014 Feb 27;97(1):64-71. doi: 10.1016/j.lfs.2013.07.011. Epub 2013 Jul 25. Review.

Items per page

Supplemental Content

Write to the Help Desk